Stem cell therapy attenuates cerebellar histological alterations and blood–brain barrier disruption in experimental fibromyalgia: involvement of mast cells, autophagy, and NLRP3/IL-1β neuroinflammatory pathway

Fibromyalgia is a prevalent and debilitating condition that results in generalized musculoskeletal pain, trouble sleeping, exhaustion, psychological challenges, and social problems. As a consequence of fibromyalgia's substantial therapeutic and socioeconomic burden caused by its high prevalence, uncertain etiology, wide spectrum of clinical manifestations, and sophisticated therapy, a considerable interest has emerged in investigating novel aspects of its pathophysiology, particularly those related to anxiety, depression, and cerebellar histological alterations. Such investigations may contribute to the development of effective therapeutic strategies, including the use of bone marrow-derived mesenchymal stem cells (BMSCs) as a promising treatment approach. Rats were randomly divided into three groups: control, fibromyalgia and fibromyalgia-stem cell groups. Behavioral assessment was carried out. Cerebellar cortices were collected for histological, immunohistochemical, and morphometric analysis. Fibromyalgia group revealed anxiety-like behavioral changes, and neurodegenerative changes with blood-brain barrier (BBB) affection. Furthermore, NLRP3 and IL-1β immune-expression were significantly increased, with significant increase in the total number of mast cells with marked degranulation. Additionally, there was a significant decrease in Calbindin D-28k (CB), Beclin-1 and LC3 immune-expression. Fibromyalgia-stem cells group revealed amelioration in behavioral alterations, histological improvement, significant decrease in CD117, NLRP3 and IL-1β immune-expression, besides a significant increase in CB, Beclin-1 and LC3 immune-expression. This study represents one of the first experimental studies investigating the potential therapeutic value of BMSCs therapy in fibromyalgia-related cerebellar damage through neuroprotective mechanisms involving enhancement of autophagy, mast cell deactivation, and suppression of NLRP3/IL-1β mediated neuroinflammation with improvement of BBB structural integrity.

Authors

Institutions

Publication Details

Journal
Tissue Barriers
Published
2026-11-13
DOI
https://doi.org/10.1080/21688370.2026.2762719
Primary Topic
Fibromyalgia and Chronic Fatigue Syndrome Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Stem cell therapy attenuates cerebellar histological alterations and blood–brain barrier disruption in experimental fibromyalgia: involvement of mast cells, autophagy, and NLRP3/IL-1β neuroinflammatory pathway

Asmaa K. Abdelghany, Sahar Ahmed Mokhemer, Salma M. Hassan, Aliaa Hamdy AbdelHaleem
1 links
Tissue Barriers
Fibromyalgia and Chronic Fatigue Syndrome Research
article

Stem cell therapy attenuates cerebellar histological alterations and blood–brain barrier disruption in experimental fibromyalgia: involvement of mast cells, autophagy, and NLRP3/IL-1β neuroinflammatory pathway

Asmaa K. Abdelghany, Sahar Ahmed Mokhemer, Salma M. Hassan, Aliaa Hamdy AbdelHaleem
article en

Abstract

Fibromyalgia is a prevalent and debilitating condition that results in generalized musculoskeletal pain, trouble sleeping, exhaustion, psychological challenges, and social problems. As a consequence of fibromyalgia's substantial therapeutic and socioeconomic burden caused by its high prevalence, uncertain etiology, wide spectrum of clinical manifestations, and sophisticated therapy, a considerable interest has emerged in investigating novel aspects of its pathophysiology, particularly those related to anxiety, depression, and cerebellar histological alterations. Such investigations may contribute to the development of effective therapeutic strategies, including the use of bone marrow-derived mesenchymal stem cells (BMSCs) as a promising treatment approach. Rats were randomly divided into three groups: control, fibromyalgia and fibromyalgia-stem cell groups. Behavioral assessment was carried out. Cerebellar cortices were collected for histological, immunohistochemical, and morphometric analysis. Fibromyalgia group revealed anxiety-like behavioral changes, and neurodegenerative changes with blood-brain barrier (BBB) affection. Furthermore, NLRP3 and IL-1β immune-expression were significantly increased, with significant increase in the total number of mast cells with marked degranulation. Additionally, there was a significant decrease in Calbindin D-28k (CB), Beclin-1 and LC3 immune-expression. Fibromyalgia-stem cells group revealed amelioration in behavioral alterations, histological improvement, significant decrease in CD117, NLRP3 and IL-1β immune-expression, besides a significant increase in CB, Beclin-1 and LC3 immune-expression. This study represents one of the first experimental studies investigating the potential therapeutic value of BMSCs therapy in fibromyalgia-related cerebellar damage through neuroprotective mechanisms involving enhancement of autophagy, mast cell deactivation, and suppression of NLRP3/IL-1β mediated neuroinflammation with improvement of BBB structural integrity.

Tissue Barriers
Beni-Suef University (EG), Minia University (EG)
Good health and well-being
Fibromyalgia and Chronic Fatigue Syndrome Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon